Evidence map›Paper›PMID 38297114›Full record

ArticleScientific reports2024

First experimental demonstration of real-time neutron capture discrimination in helium and carbon ion therapy.

Marissa Kielly, Anita Caracciolo, Andrew Chacon, James Vohradsky, Davide Di Vita, Akram Hamato, Hideaki Tashima, Daniel R Franklin, Taiga Yamaya, Anatoly Rosenfeld and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 3 countries.

Marissa KiellyAustralian Nuclear Science and Technology Organisation (ANSTO), Lucas Heights, Australia.
Anita CaraccioloDipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy.
Andrew ChaconAustralian Nuclear Science and Technology Organisation (ANSTO), Lucas Heights, Australia.
James VohradskyCentre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia.
Davide Di VitaDipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy.
Akram HamatoImaging Physics Group, Department of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology (QST), Inage-ku, Chiba, Japan.
Hideaki TashimaImaging Physics Group, Department of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology (QST), Inage-ku, Chiba, Japan.
Daniel R FranklinSchool of Electrical and Data Engineering, University of Technology Sydney, Sydney, Australia.
Taiga YamayaImaging Physics Group, Department of Advanced Nuclear Medicine Sciences, National Institutes for Quantum Science and Technology (QST), Inage-ku, Chiba, Japan.
Anatoly RosenfeldCentre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia.
Marco CarminatiDipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy.
Carlo FioriniDipartimento di Elettronica, Informazione e Bioingegneria, Politecnico di Milano, Milan, Italy.
Susanna GuatelliCentre for Medical Radiation Physics, University of Wollongong, Wollongong, Australia.
Mitra Safavi-NaeiniAustralian Nuclear Science and Technology Organisation (ANSTO), Lucas Heights, Australia. mitras@ansto.gov.au.
University of Wollongong · AUIstituto Nazionale di Fisica Nucleare, Sezione di Milano · ITNational Institutes for Quantum and Radiological Science and Technology · JPAustralian Nuclear Science and Technology Organisation · AUPolitecnico di Milano · ITUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work provides the first experimental proof of an increased neutron capture photon signal following the introduction of boron to a PMMA phantom during helium and carbon ion therapies in Neutron Capture Enhanced Particle Therapy (NCEPT). NCEPT leverages [Formula: see text]B neutron capture, leading to the emission of detectable 478 keV photons. Experiments were performed at the Heavy Ion Medical Accelerator in Chiba, Japan, with two Poly(methyl methacrylate) (PMMA) targets, one bearing a boron insert. The BeNEdiCTE gamma-ray detector measured an increase in the 478 keV signal of 45 ± 7% and 26 ± 2% for carbon and helium ion irradiation, respectively. Our Geant4 Monte Carlo simulation model, developed to investigate photon origins, found less than 30% of detected photons originated from the insert, while boron in the detector's circuit boards contributed over 65%. Further, the model investigated detector sensitivity, establishing its capability to record a 10% increase in 478 keV photon detection at a target [Formula: see text]B concentration of 500 ppm using spectral windowing alone, and 25% when combined with temporal windowing. The linear response extended to concentrations up to 20,000 ppm. The increase in the signal in all evaluated cases confirm the potential of the proposed detector design for neutron capture quantification in NCEPT.

Identifiers

PMID38297114
PMCPMC10831067
OpenAlexW4391386307

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.